e-learning
resources
London 2016
Sunday, 04.09.2016
Drugs, bugs, BMI, and other problems in paediatric asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analysis of the inflammatory profile of children with controlled and uncontrolled severe asthma
Miriam Eller (São Paulo, Brazil), Miriam Eller, Karina Vergani, Beatriz Saraiva-Romanholo, Leila Antonangelo, Thais Mauad, Joaquim Rodrigues
Source:
International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Session:
Drugs, bugs, BMI, and other problems in paediatric asthma
Session type:
Thematic Poster
Number:
1255
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Miriam Eller (São Paulo, Brazil), Miriam Eller, Karina Vergani, Beatriz Saraiva-Romanholo, Leila Antonangelo, Thais Mauad, Joaquim Rodrigues. Analysis of the inflammatory profile of children with controlled and uncontrolled severe asthma. Eur Respir J 2016; 48: Suppl. 60, 1255
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Obesity influences inflammatory phenotype mainly in early onset severe asthmatics
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Implication of IL-18 in the chronic inflammation of severe refractory asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Systemic cytokine signaling via IL-17 and its relation to clinical characteristics in children with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Various biomarkers of oxidative stress in patients with uncontrolled asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Biomarkers of obesity associated with severe atopic asthma
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
Systemic inflammation, comorbidities and the outcome of adult-onset asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
T
H
2 specific biomarker profile determines steroid responsiveness in severe asthma
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Associated factors with persistent airflow limitation in asthma in U-BIOPRED
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Evaluation of inflammatory markers IL-6 and MMP-9 in asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Coagulation activity increases with disease severity in patients with asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Relation of hemogram parameters with asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Eosinophilic inflammation amplifies the prednisolone-induced prothrombotic state in asthma
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept